These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 11118363

  • 1. Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge.
    Zuber B, Hinkula J, Vödrös D, Lundholm P, Nilsson C, Mörner A, Levi M, Benthin R, Wahren B.
    Virology; 2000 Dec 20; 278(2):400-11. PubMed ID: 11118363
    [Abstract] [Full Text] [Related]

  • 2. Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy.
    Nakayama D, Misumi S, Mukai R, Tachibana K, Umeda M, Shibata H, Takamune N, Shoji S.
    J Biochem; 2005 Nov 20; 138(5):571-82. PubMed ID: 16272569
    [Abstract] [Full Text] [Related]

  • 3. Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts.
    Putkonen P, Quesada-Rolander M, Leandersson AC, Schwartz S, Thorstensson R, Okuda K, Wahren B, Hinkula J.
    Virology; 1998 Oct 25; 250(2):293-301. PubMed ID: 9792840
    [Abstract] [Full Text] [Related]

  • 4. Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.
    Barassi C, Soprana E, Pastori C, Longhi R, Buratti E, Lillo F, Marenzi C, Lazzarin A, Siccardi AG, Lopalco L.
    J Virol; 2005 Jun 25; 79(11):6848-58. PubMed ID: 15890924
    [Abstract] [Full Text] [Related]

  • 5. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B, Derby NR, Kraft Z, Saunders CJ, Dai C, Llewellyn N, Zharkikh I, Vojtech L, Zhu T, Srivastava IK, Barnett SW, Stamatatos L.
    Virology; 2006 Nov 25; 355(2):138-51. PubMed ID: 16920175
    [Abstract] [Full Text] [Related]

  • 6. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
    Egan MA, Chong SY, Hagen M, Megati S, Schadeck EB, Piacente P, Ma BJ, Montefiori DC, Haynes BF, Israel ZR, Eldridge JH, Staats HF.
    Vaccine; 2004 Sep 09; 22(27-28):3774-88. PubMed ID: 15315859
    [Abstract] [Full Text] [Related]

  • 7. Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus.
    Chackerian B, Briglio L, Albert PS, Lowy DR, Schiller JT.
    J Virol; 2004 Apr 09; 78(8):4037-47. PubMed ID: 15047820
    [Abstract] [Full Text] [Related]

  • 8. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
    Laurén A, Vincic E, Hoshino H, Thorstensson R, Fenyö EM.
    Retrovirology; 2007 Jul 23; 4():50. PubMed ID: 17645788
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B.
    Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672
    [Abstract] [Full Text] [Related]

  • 11. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
    Pal R, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Markham P, Lu S.
    Virology; 2006 May 10; 348(2):341-53. PubMed ID: 16460776
    [Abstract] [Full Text] [Related]

  • 12. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS, Park KS, Sauermann U, Franz M, Norley S, Wilfingseder D, Stoiber H, Fagrouch Z, Heeney J, Hunsmann G, Stahl-Hennig C, Sung YC.
    Vaccine; 2006 Mar 10; 24(11):1811-20. PubMed ID: 16274888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ, Dale CJ, Ranasinghe C, Stratov I, De Rose R, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Wilson KM, Ramsay AJ.
    Vaccine; 2005 Oct 10; 23(42):5009-21. PubMed ID: 15985317
    [Abstract] [Full Text] [Related]

  • 15. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y.
    Vaccine; 2008 Nov 11; 26(48):6124-31. PubMed ID: 18812199
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.